Insights
Peptide Industry Insights & Sourcing Guides
Expert analysis on peptide API technologies, global compliance, and supply chain dynamics.
2026-05-16
Retatrutide API Global Supply-Demand Research Report: China Supply Chain Analysis and Advantages
Global Retatrutide API Supply-Demand Research Report: China Supply Chain Analysis and Advantages
Intended audience: pharmaceutical companies, CDMOs, CROs, API distributors, qualified B2B buyers and pharmaceutical supply-chain decision makers
Compliance positioning: This document is intended only for B2B market research, supply-chain evaluation and technical communication. It does not constitute drug advertising, medical advice, treatment advice or a direct sales offer. Retatrutide-related APIs, intermediates or research materials are not for personal use or direct consumer sale. The buyer is responsible for confirming local registration, import, intellectual property, end-use and regulatory compliance requirements.
2026-05-17
Global Tirzepatide Intermediates Supply-Demand Landscape and China Supply Chain Advantages
An overview of Tirzepatide-related supply considerations, China-side resources, documentation requirements and procurement factors for qualified B2B buyers.
2026-08-11
SPPS Technical Barriers in GLP-1 Peptide API Development
A technical overview of SPPS process risks in GLP-1 class peptide API development, from resin-phase coupling and sequence impurities to purification and batch comparability.
2026-08-11
KPV API CAS 67727-97-3 Technical Profile
Comprehensive technical profile of KPV API (CAS 67727-97-3), including molecular details, specifications, storage, and B2B supply information.
2026-08-10
Tirzepatide API CAS 2023788-19-2 Technical Profile
Comprehensive technical profile of Tirzepatide API (CAS 2023788-19-2) covering molecular details, specifications, testing, storage, and B2B supply considerations.
2026-08-10
Understanding the Significance of DMF, ASMF, and CEP for Overseas API Buyers
This article explains the roles and importance of DMF, ASMF, and CEP documents in the procurement and regulatory evaluation of Active Pharmaceutical Ingredients (APIs) by overseas buyers, focusing on quality assurance, supplier qualification, and regulatory compliance.
2026-08-09
Tesamorelin API Procurement Guide: COA and Batch Documentation Review for B2B Buyers
This guide provides pharmaceutical procurement and quality teams with detailed steps to review Tesamorelin API Certificates of Analysis (COA) and batch documentation. It focuses on key quality documents, supplier qualification, and regulatory considerations essential for B2B API sourcing.
2026-08-05
Epitalon Technical Documents: COA, HPLC, LC-MS and Batch Review
A document-by-document guide to reviewing Epitalon sequence, purity, identity, specification and batch traceability using the current COA, HPLC, LC-MS and specification records.
2026-08-02
TB-500 Technical Documents: COA, HPLC, Specification and Batch Review
A document-by-document guide to reviewing TB-500 identity, sequence, purity, specification and batch traceability using the current COA, HPLC and specification records.
2026-07-26
BPC-157 Peptide Technical Documents: COA, HPLC, LC-MS and Batch Review
A document-by-document guide to reviewing BPC-157 identity, purity, specification and batch traceability using the current COA, HPLC, LC-MS and specification records.
